MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene
- PMID: 30229899
- DOI: 10.1002/jcp.27020
MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene
Retraction in
-
Retraction.J Cell Physiol. 2022 Apr;237(4):2294. doi: 10.1002/jcp.30633. Epub 2021 Dec 6. J Cell Physiol. 2022. PMID: 34873697
Abstract
Renal cell carcinoma (RCC) is the most common malignancy involving the kidneys and a major cause of cancer mortality. The involvement of microRNA (miRNA) expression in the tumorigenesis and progression of RCC has been previously highlighted. Therefore, we conducted this study to investigate whether microRNA-363 (miR-363) affects the development of RCC via the Janus tyrosine kinases (JAK2)-signal transducers and activators of transcription (STAT) axis by targeting the growth hormone receptor (GHR), by observing the changes that occurred in the RCC and the normal adjacent tissues of patients with RCC. RCC cells were transfected with a series of miR-363 mimic, miR-363 inhibitor, or small interfering RNA against GHR to determine the influence of miR-363 on the expression of GHR and JAK2-STAT3 axis-related genes with the use of reverse transcription quantitative polymerase chain reaction and Western blot analysis. The angiogenesis, viability, invasion, and migration of cells were evaluated by means of in vitro angiogenesis, 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT), wound-healing, and Transwell assays. The results revealed reduced miR-363 expression and elevated GHR expression in RCC. It was also found that miR-363 altered the activation of the JAK2-STAT3 axis through the inhibition of GHR. Cells treated with the miR-363 inhibitor presented with increased capillary vessels, cell viability, invasion, and migration, whereas it was on the contrary in the RCC cells with overexpressed miR-363. These results implicated that the overexpression of miR-363 could specifically bind to GHR to downregulate the expression of GHR, which, in turn, inactivates the JAK2-STAT3 axis, thereby influencing the angiogenesis, cell invasion, and migration abilities in RCC.
Keywords: Janus tyrosine kinases-signal transducers and activators of transcription (JAK2-STAT3) axis; angiogenesis; growth hormone receptor (GHR); invasion; microRNA-363 (miR-363); migration; renal cell carcinoma (RCC).
© 2018 Wiley Periodicals, Inc.
Similar articles
-
MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.J Cell Biochem. 2019 Feb;120(2):1894-1902. doi: 10.1002/jcb.27503. Epub 2018 Sep 6. J Cell Biochem. 2019. PMID: 30187954
-
Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.Mol Med Rep. 2017 Oct;16(4):4273-4278. doi: 10.3892/mmr.2017.7093. Epub 2017 Jul 27. Mol Med Rep. 2017. PMID: 28765891
-
The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.Cancer Biomark. 2017 Jul 4;19(3):289-296. doi: 10.3233/CBM-160449. Cancer Biomark. 2017. PMID: 28453463
-
Post-Receptor Inhibitors of the GHR-JAK2-STAT Pathway in the Growth Hormone Signal Transduction.Int J Mol Sci. 2018 Jun 22;19(7):1843. doi: 10.3390/ijms19071843. Int J Mol Sci. 2018. PMID: 29932147 Free PMC article. Review.
-
JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review.Eur J Pharmacol. 2024 May 5;970:176490. doi: 10.1016/j.ejphar.2024.176490. Epub 2024 Mar 15. Eur J Pharmacol. 2024. PMID: 38492876 Review.
Cited by
-
Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases.Cells. 2021 Jun 27;10(7):1610. doi: 10.3390/cells10071610. Cells. 2021. PMID: 34199002 Free PMC article. Review.
-
[MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Jan 30;40(1):61-66. doi: 10.12122/j.issn.1673-4254.2020.01.10. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32376567 Free PMC article. Chinese.
-
Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma.Sci Rep. 2025 Apr 3;15(1):11461. doi: 10.1038/s41598-025-95865-3. Sci Rep. 2025. Retraction in: Sci Rep. 2025 Jul 15;15(1):25508. doi: 10.1038/s41598-025-10487-z. PMID: 40181069 Free PMC article. Retracted.
-
MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1.Front Genet. 2020 Jan 30;10:1397. doi: 10.3389/fgene.2019.01397. eCollection 2019. Front Genet. 2020. PMID: 32082362 Free PMC article.
-
A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.Med Sci Monit. 2021 May 8;27:e930639. doi: 10.12659/MSM.930639. Med Sci Monit. 2021. PMID: 33963171 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous